Dividend Assets Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-120
Closed -$2K 300
2023
Q4
$2K Sell
120
-21
-15% -$286 ﹤0.01% 461
2023
Q3
$2K Buy
141
+1
+0.7% +$21 ﹤0.01% 472
2023
Q2
$3K Sell
140
-2
-1% -$43 ﹤0.01% 477
2023
Q1
$4K Hold
142
﹤0.01% 495
2022
Q4
$4K Sell
142
-136
-49% -$3.48K ﹤0.01% 495
2022
Q3
$7K Hold
278
﹤0.01% 473
2022
Q2
$9K Sell
278
-15
-5% -$525 ﹤0.01% 466
2022
Q1
$10K Hold
293
﹤0.01% 436
2021
Q4
$9K Sell
293
-20
-6% -$651 ﹤0.01% 430
2021
Q3
$10K Sell
313
-115
-27% -$3.68K ﹤0.01% 423
2021
Q2
$13K Buy
+428
New +$14.1K ﹤0.01% 410

Other funds holding OGN

Dividend Assets Capital's OGN Position: Q1 2024 in Review

Dividend Assets Capital sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 120 shares — an estimated $2K sold.

Dividend Assets Capital first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $13K in Q2 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Dividend Assets Capital reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Dividend Assets Capital sold 120 Organon & Co shares in Q1 2024, an estimated $2K.
  • Dividend Assets Capital first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Dividend Assets Capital's Organon & Co position peaked at $13K in Q2 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Dividend Assets Capital's 13F filing for Q1 2024, filed 15 May 2024.